Analysis of National Pharmacovigilance Data Associated with Statin Use in Korea

Basic & Clinical Pharmacology & Toxicology
Hyunah KimHun-Sung Kim

Abstract

The aim of this study was to evaluate clinical manifestations, age distribution and risk factors of adverse drug reactions (ADRs) of statins. Korean Adverse Event Reporting System (KAERS) database records (July 2009-June 2014) on statin-treated adults were used. ADRs classified as 'certain', 'probable' and 'possible' based on the WHO-Uppsala Monitoring Centre criteria were analysed. The frequency of ADRs was compared between adults (18-64 years) and older people (age ≥65 years) groups. In total, 2161 ADRs from 1690 patients (579, 34.3% older people) were included for analysis. Mean patient age and ADRs per patient were 60.46 ± 12.72 years and 1.28, respectively. ADRs were reported with atorvastatin (48.4%), rosuvastatin (23.0%), pitavastatin (10.4%) and simvastatin (9.1%). The frequent ADRs were gastrointestinal (421 events, 19.5%), musculoskeletal (331, 15.3%), skin (312, 14.4%) and hepatobiliary disorders (286, 13.2%). Skin disorders were significantly more frequent in adults compared to those in older patients (16.3% versus 12.4%, p = 0.021). Common clinical symptoms were myalgia (263 events, 12.2%), dyspepsia (133, 6.2%) and pruritus (103, 4.8%). Myalgia was more frequently reported in adults (12.7% versus 9.5%, p = 0.039) ...Continue Reading

References

Mar 25, 2000·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·T K GandhiD W Bates
Nov 10, 2000·Lancet·I R Edwards, J K Aronson
May 11, 2001·Annals of Internal Medicine·P D SloaneJ Dallara
Jan 5, 2002·The American Journal of Geriatric Cardiology·Domenic A Sica, Todd W B Gehr
Dec 31, 2002·The Annals of Pharmacotherapy·Hélène PeyriereSylvie Hansel
Aug 30, 2003·Expert Opinion on Drug Safety·Petra A Thürmann
Jan 8, 2004·Mayo Clinic Proceedings·Darryl S ChutkaRobert W Hoel
Aug 8, 2006·Pharmacoepidemiology and Drug Safety·Stephanie SchechDeborah Shatin
Apr 10, 2008·BMJ : British Medical Journal·Jerry Avorn, William H Shrank
Dec 17, 2008·Current Atherosclerosis Reports·Saadi A Siddiqi, Paul D Thompson
Mar 21, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Joseph L Goldstein, Michael S Brown
May 12, 2010·Annals of Family Medicine·Otto R MaarsinghHenriette E van der Horst
Nov 4, 2010·Current Atherosclerosis Reports·Sridevi DevarajIshwarlal Jialal
Apr 12, 2011·International Journal of Geriatric Psychiatry·Chia-Ming ChangChia-Yih Liu
Jan 11, 2012·Archives of Internal Medicine·Annie L CulverYunsheng Ma
Mar 21, 2013·BMJ : British Medical Journal·Colin R DormuthUNKNOWN Canadian Network for Observational Drug Effect Studies
Dec 7, 2013·Southern Medical Journal·Divey ManochaSharon Brangman
Mar 1, 2010·International Journal of Psychiatry in Clinical Practice·Agnes L F Chan, Shun-Jin Lin
Dec 6, 2014·The Canadian Journal of Cardiology·Stephanie J WiseG B John Mancini
Feb 1, 2015·The American Journal of Cardiology·Priscilla Y HsueDavid D Waters
Mar 31, 2015·The Canadian Journal of Cardiology·Todd J AndersonRobert A Hegele
May 6, 2015·Cardiology Clinics·Cynthia HerrickEdward A Gill

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.